Skip to main content

LUP Student Papers

LUND UNIVERSITY LIBRARIES

Pharming from A to Z

Hennig, Erik LU ; Gränsbo, Sofie LU ; Pedersen, Jonathan LU and Jörntén, Marcus LU (2020) FEKH19 20192
Department of Business Administration
Abstract
Purpose: This thesis purpose is to see how pharmaceutical companies can use the Transaction Cost Economics theory in their decision making in regards to the make, buy or ally decision when a new market emerges.
Method: This is a basic case study that focuses on the pharmaceutical company AstraZeneca. It has an idiographic approach, and several semi-structured interviews have taken place. Pattern-matching has been used in order to analyse the qualitative research data, with an abductive approach.
Theoretical perspective: The Transaction Cost Economics theory’s real world implications. Vertical integration versus strategic alliance.
Results: The Transaction Cost Economics theory can to some extent help pharmaceutical companies in their... (More)
Purpose: This thesis purpose is to see how pharmaceutical companies can use the Transaction Cost Economics theory in their decision making in regards to the make, buy or ally decision when a new market emerges.
Method: This is a basic case study that focuses on the pharmaceutical company AstraZeneca. It has an idiographic approach, and several semi-structured interviews have taken place. Pattern-matching has been used in order to analyse the qualitative research data, with an abductive approach.
Theoretical perspective: The Transaction Cost Economics theory’s real world implications. Vertical integration versus strategic alliance.
Results: The Transaction Cost Economics theory can to some extent help pharmaceutical companies in their decision making in regards to the make, buy or ally decision. Though there are other factors outside of the theory that can further explain the decision. (Less)
Please use this url to cite or link to this publication:
author
Hennig, Erik LU ; Gränsbo, Sofie LU ; Pedersen, Jonathan LU and Jörntén, Marcus LU
supervisor
organization
alternative title
A case study of AstraZeneca’s strategic decision to go Beyond the Pill
course
FEKH19 20192
year
type
M2 - Bachelor Degree
subject
keywords
Pharmaceutical industry, Digital Health services, AstraZeneca, Transaction Cost Economics, Strategic alliances, Vertical integration, New markets.
language
English
id
9006016
date added to LUP
2020-03-10 10:36:26
date last changed
2020-03-10 10:36:26
@misc{9006016,
  abstract     = {{Purpose: This thesis purpose is to see how pharmaceutical companies can use the Transaction Cost Economics theory in their decision making in regards to the make, buy or ally decision when a new market emerges. 
Method: This is a basic case study that focuses on the pharmaceutical company AstraZeneca. It has an idiographic approach, and several semi-structured interviews have taken place. Pattern-matching has been used in order to analyse the qualitative research data, with an abductive approach.
Theoretical perspective: The Transaction Cost Economics theory’s real world implications. Vertical integration versus strategic alliance. 
Results: The Transaction Cost Economics theory can to some extent help pharmaceutical companies in their decision making in regards to the make, buy or ally decision. Though there are other factors outside of the theory that can further explain the decision.}},
  author       = {{Hennig, Erik and Gränsbo, Sofie and Pedersen, Jonathan and Jörntén, Marcus}},
  language     = {{eng}},
  note         = {{Student Paper}},
  title        = {{Pharming from A to Z}},
  year         = {{2020}},
}